Ruiz Ortega M, Pogorelyy M, Minervina A, Thomas P, Mora T, Walczak A
PLoS Comput Biol. 2025; 21(1):e1012724.
PMID: 39761303
PMC: 11737854.
DOI: 10.1371/journal.pcbi.1012724.
Lo W, Huseby E
J Exp Med. 2024; 221(10).
PMID: 39167074
PMC: 11338286.
DOI: 10.1084/jem.20230897.
Pourhashem Z, Nourani L, Pirahmadi S, Yousefi H, Sani J, Raz A
PLoS One. 2024; 19(7):e0306664.
PMID: 38968270
PMC: 11226095.
DOI: 10.1371/journal.pone.0306664.
Boyd L, Jiang J, Ahmad J, Natarajan K, Margulies D
J Immunol. 2024; 212(8):1366-1380.
PMID: 38456672
PMC: 10982845.
DOI: 10.4049/jimmunol.2300839.
Acuto O
Front Immunol. 2024; 15:1343575.
PMID: 38415261
PMC: 10896960.
DOI: 10.3389/fimmu.2024.1343575.
Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction.
Boyd L, Jiang J, Ahmad J, Natarajan K, Margulies D
bioRxiv. 2023; .
PMID: 38106040
PMC: 10723347.
DOI: 10.1101/2023.12.01.569627.
Bw4 ligand and direct T-cell receptor binding induced selection on HLA A and B alleles.
Levi R, Levi L, Louzoun Y
Front Immunol. 2023; 14:1236080.
PMID: 38077375
PMC: 10703150.
DOI: 10.3389/fimmu.2023.1236080.
SARS-CoV-2 infection establishes a stable and age-independent CD8 T cell response against a dominant nucleocapsid epitope using restricted T cell receptors.
Choy C, Chen J, Li J, Gallagher D, Lu J, Wu D
Nat Commun. 2023; 14(1):6725.
PMID: 37872153
PMC: 10593757.
DOI: 10.1038/s41467-023-42430-z.
The CD4+ T cell repertoire specific for citrullinated peptides shows evidence of immune tolerance.
McElwee M, Dileepan T, Mahmud S, Jenkins M
J Exp Med. 2023; 220(12).
PMID: 37831103
PMC: 10570851.
DOI: 10.1084/jem.20230209.
Antibody Cross-Reactivity in Auto-Immune Diseases.
Trier N, Houen G
Int J Mol Sci. 2023; 24(17).
PMID: 37686415
PMC: 10487534.
DOI: 10.3390/ijms241713609.
Naive and memory T cells TCR-HLA-binding prediction.
Glazer N, Akerman O, Louzoun Y
Oxf Open Immunol. 2023; 3(1):iqac001.
PMID: 36846560
PMC: 9914496.
DOI: 10.1093/oxfimm/iqac001.
Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules.
Papadaki G, Ani O, Florio T, Young M, Danon J, Sun Y
Front Immunol. 2023; 14:1116906.
PMID: 36761745
PMC: 9905809.
DOI: 10.3389/fimmu.2023.1116906.
Simultaneous editing of TCR, HLA-I/II and HLA-E resulted in enhanced universal CAR-T resistance to allo-rejection.
Li W, Zhu X, Xu Y, Chen J, Zhang H, Yang Z
Front Immunol. 2022; 13:1052717.
PMID: 36532006
PMC: 9757162.
DOI: 10.3389/fimmu.2022.1052717.
Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs).
Cassioli C, Patrussi L, Valitutti S, Baldari C
Int J Mol Sci. 2022; 23(22).
PMID: 36430728
PMC: 9694822.
DOI: 10.3390/ijms232214255.
A class-mismatched TCR bypasses MHC restriction via an unorthodox but fully functional binding geometry.
Singh N, Alonso J, Devlin J, Keller G, Gray G, Chiranjivi A
Nat Commun. 2022; 13(1):7189.
PMID: 36424374
PMC: 9691722.
DOI: 10.1038/s41467-022-34896-0.
A Beginner's Guide to T Cell Development.
Bosselut R
Methods Mol Biol. 2022; 2580:3-24.
PMID: 36374448
DOI: 10.1007/978-1-0716-2740-2_1.
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.
Pagliuca S, Gurnari C, Rubio M, Visconte V, Lenz T
Front Immunol. 2022; 13:944872.
PMID: 36131910
PMC: 9483928.
DOI: 10.3389/fimmu.2022.944872.
A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice.
Li W, Zhang Y, Li R, Wang Y, Chen L, Dai S
Front Immunol. 2022; 13:877022.
PMID: 36032077
PMC: 9406144.
DOI: 10.3389/fimmu.2022.877022.
Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response.
Wang Y, Tsitsiklis A, Devoe S, Gao W, Chu H, Zhang Y
Front Immunol. 2022; 13:847092.
PMID: 35967379
PMC: 9372435.
DOI: 10.3389/fimmu.2022.847092.
MHC-independent αβT cells: Lessons learned about thymic selection and MHC-restriction.
Van Laethem F, Bhattacharya A, Craveiro M, Lu J, Sun P, Singer A
Front Immunol. 2022; 13:953160.
PMID: 35911724
PMC: 9331304.
DOI: 10.3389/fimmu.2022.953160.